Compare LULU & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LULU | ICLR |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | Canada | Ireland |
| Employees | N/A | 40100 |
| Industry | Apparel | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 13.1B |
| IPO Year | 2007 | 2001 |
| Metric | LULU | ICLR |
|---|---|---|
| Price | $97.66 | $173.95 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 25 | 13 |
| Target Price | ★ $190.26 | $178.62 |
| AVG Volume (30 Days) | ★ 6.3M | 685.4K |
| Earning Date | 06-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.59 | N/A |
| Revenue | ★ $11,102,600,000.00 | N/A |
| Revenue This Year | $5.52 | N/A |
| Revenue Next Year | $4.68 | N/A |
| P/E Ratio | $21.43 | ★ $12.91 |
| Revenue Growth | ★ 4.86 | N/A |
| 52 Week Low | $95.67 | $66.57 |
| 52 Week High | $225.98 | $203.91 |
| Indicator | LULU | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 58.08 |
| Support Level | N/A | $162.06 |
| Resistance Level | N/A | $183.11 |
| Average True Range (ATR) | 0.00 | 5.92 |
| MACD | 0.00 | 0.54 |
| Stochastic Oscillator | 0.00 | 83.20 |
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 800 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 45 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.